UBS Group

UBS Group’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

UBS Group’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$1.27M	Buy
2023 Q2	$38K	Buy
2023 Q1	$22.1K	Buy
2022 Q4	$7.8K	Buy
2022 Q3	–	Sell
2022 Q2	$8K	Sell
2022 Q1	$12K	Sell
2021 Q4	$35K	Buy